Recent breakthroughs in epigenetic clocks, particularly DunedinPACE, enhance mortality prediction accuracy by up to 20%, validated by studies like BASE-II, and drive innovations in personalized medici...
Recent studies validate blood biomarkers like p-tau217 for predicting Alzheimer’s onset within 3-4 years at 94% accuracy, enabling early interventions but raising ethical and socioeconomic conce...
